Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks

Status:	Terminated
Conditions:	Chronic Pain
Therapuetic Areas:	Musculoskeletal
Healthy:	No
Age Range:	18 - 79
Updated:	2/20/2019
Start Date:	June 2011
End Date:	February 2016

Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting

The primary hypothesis is that those patients who choose an interscalene catheter will have
less pain postoperatively than those with single injection blocks. Secondary hypotheses
examine physical therapy outcomes and incidence of parasthesia or pain following surgery for
up to 3 months.

Inclusion Criteria:

- American Society of Anesthesiologists (ASA) physical status 1-3

- 18-79 years of age, inclusive

- body mass index of < 36 kg/m2.

- The ability to understand local anesthetic related complications and care of a CPNB

- Presence of a caretaker with them during the first 24 hours of local anesthetic
infusion, and on a daily basis.

- The ability to communicate with the practitioner managing the catheter.

- Residence within 2 hours of University of Wisconsin Hospital and Clinics

Exclusion Criteria:

- Any contraindication to a continuous interscalene catheter placement

- Clinically significant pulmonary disease

- Clinically significant cardiac disease

- Allergy to ropivacaine

- Peripheral or central nervous system disease

- Current (or planned) anticoagulation therapy or disease

- Local infection over area of catheter placement

- Renal or hepatic failure

- History of opioid dependence

- Significant psychiatric disease

- Pregnancy or lactation (Subjects will be asked if it is possible they could be
pregnant. If a subject responds in the affirmative, a pregnancy test will be done.)

- Seizure Disorder

We found this trial at

sites

University of Wisconsin

Madison, Wisconsin 53792

(608) 263-2400